Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9851
CALL
Oxford Industries
OXM
$539M
| $268K | ﹤0.01% |
3,400
-11,200
| -77% | -$878K |
|
9852
PUT
LeMaitre Vascular
LMAT
$1.88B
| $267K | ﹤0.01% |
2,900
| – | – |
|
9853
Perion Network
PERI
$381M
| $267K | ﹤0.01% |
31,541
+28,520
| +944% | +$240K |
|
9854
PUT
Genmab
GMAB
$20.2B
| $267K | ﹤0.01% |
12,800
+4,600
| +56% | +$101K |
|
9855
CALL
AptarGroup
ATR
$8.41B
| $267K | ﹤0.01% |
1,700
-1,900
| -53% | -$317K |
|
9856
CALL
Knowles
KN
$3.36B
| $267K | ﹤0.01% |
13,400
-300
| -2% | -$5.58K |
|
9857
PUT
Kaiser Aluminum
KALU
$3.03B
| $267K | ﹤0.01% |
3,800
-3,600
| -49% | -$274K |
|
9858
CALL
Avnet
AVT
$8.04B
| $267K | ﹤0.01% |
5,100
-32,400
| -86% | -$1.76M |
|
9859
PUT
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.86B
| $267K | ﹤0.01% |
6,100
+2,300
| +61% | +$101K |
|
9860
CALL
Core Laboratories
CLB
$580M
| $267K | ﹤0.01% |
15,400
-7,800
| -34% | -$151K |
|
|
CYPH
9861
Cypherpunk Technologies Inc
CYPH
$76.4M
| $267K | ﹤0.01% |
92,709
-370,739
| -80% | -$1.1M |
|
9862
CALL
Centuri Holdings
CTRI
$2.41B
| $266K | ﹤0.01% |
+13,800
| New | +$268K |
|
9863
PUT
Collegium Pharmaceutical
COLL
$883M
| $266K | ﹤0.01% |
9,300
-500
| -5% | -$16.5K |
|
9864
CALL
Daktronics
DAKT
$960M
| $266K | ﹤0.01% |
15,800
-28,900
| -65% | -$436K |
|
9865
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.95B
| $266K | ﹤0.01% |
+14,234
| New | +$268K |
|
9866
Belden
BDC
$5.39B
| $266K | ﹤0.01% |
2,363
-317
| -12% | -$37.8K |
|
|
WW
9867
PUT
DELISTED
WW International
WW
| $266K | ﹤0.01% |
209,400
+114,700
| +121% | +$138K |
|
|
ARIS
9868
PUT
DELISTED
Aris Water Solutions
ARIS
| $266K | ﹤0.01% |
11,100
+6,200
| +127% | +$135K |
|
|
AFCG
9869
AFC Gamma
AFCG
$78.2M
| $265K | ﹤0.01% |
+31,860
| New | +$306K |
|
|
BASE
9870
CALL
DELISTED
Couchbase
BASE
| $265K | ﹤0.01% |
17,000
+1,700
| +11% | +$29K |
|
9871
ProShares Ultra Utilities
UPW
$17.4M
| $265K | ﹤0.01% |
+14,816
| New | +$293K |
|
9872
PUT
Rani Therapeutics
RANI
$89.4M
| $265K | ﹤0.01% |
193,300
+191,100
| +8,686% | +$402K |
|
|
XRN
9873
CALL
Chiron Real Estate Inc
XRN
$481M
| $265K | ﹤0.01% |
6,860
-720
| -9% | -$31.9K |
|
9874
CALL
American Battery Technology Co
ABAT
$330M
| $265K | ﹤0.01% |
107,600
+98,100
| +1,033% | +$110K |
|
9875
FT Vest US Equity Max Buffer ETF March
MARM
$110M
| $265K | ﹤0.01% |
8,569
+482
| +6% | +$14.8K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.